TD Cowen Maintains Buy on Vericel, Raises Price Target to $58
TD Cowen analyst Joshua Jennings maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $55 to $58.
Read original at benzingaStocks · News reference
HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $72
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $70 to $72.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 31, 2026, 10:09 AM
- Checked
- Jul 31, 2026, 10:08 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Truist Securities Reiterates Buy on Vericel, Raises Price Target to $58
Read original at benzingaVericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program
Vericel Corporation reported strong Q2 2026 results with total revenue increasing 22% to $77.5 million and MACI revenue growing 23%. The company raised its full-year 2026 revenue guidance to $330-$340 million and announced a $200 million share repurchase program. Net income reached $2.2 million with free cash flow of $14.3 million, demonstrating sustained profitability and cash generation.
Read original at globenewswire-inc